These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32093016)

  • 1. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus.
    Pittala S; Levy I; De S; Kumar Pandey S; Melnikov N; Hyman T; Shoshan-Barmatz V
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
    Pittala S; Krelin Y; Shoshan-Barmatz V
    Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model.
    Pittala S; Krelin Y; Kuperman Y; Shoshan-Barmatz V
    Mol Ther; 2019 Oct; 27(10):1848-1862. PubMed ID: 31375359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
    Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
    Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
    Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
    Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism.
    Tian G; Zhou J; Quan Y; Kong Q; Li J; Xin Y; Wu W; Tang X; Liu X
    Redox Biol; 2023 Nov; 67():102907. PubMed ID: 37797372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.
    Shteinfer-Kuzmine A; Arif T; Krelin Y; Tripathi SS; Paul A; Shoshan-Barmatz V
    Oncotarget; 2017 May; 8(19):31329-31346. PubMed ID: 28412744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.
    Ma H; Cui F; Dong JJ; You GP; Yang XJ; Lu HD; Huang YL
    World J Gastroenterol; 2014 Oct; 20(40):14950-7. PubMed ID: 25356056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
    Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
    Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
    Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
    Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
    Nath S; Ghosh SK; Choudhury Y
    J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modulatory role of prime identified compounds in the bioactive fraction of Homalium zeylanicum in high-fat diet fed-streptozotocin-induced type 2 diabetic rats.
    Rout D; Chandra Dash U; Kanhar S; Swain SK; Sahoo AK
    J Ethnopharmacol; 2020 Oct; 260():113099. PubMed ID: 32535241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells.
    Zhang E; Mohammed Al-Amily I; Mohammed S; Luan C; Asplund O; Ahmed M; Ye Y; Ben-Hail D; Soni A; Vishnu N; Bompada P; De Marinis Y; Groop L; Shoshan-Barmatz V; Renström E; Wollheim CB; Salehi A
    Cell Metab; 2019 Jan; 29(1):64-77.e6. PubMed ID: 30293774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
    Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
    Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CAPE-pNO
    Li S; Huang Q; Zhang L; Qiao X; Zhang Y; Tang F; Li Z
    Eur J Pharmacol; 2019 Jun; 853():1-10. PubMed ID: 30885574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis.
    Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M
    Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
    Medras ZJH; El-Sayed NM; Zaitone SA; Toraih EA; Sami MM; Moustafa YM
    Pharmacol Rep; 2018 Apr; 70(2):233-242. PubMed ID: 29475006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice.
    Yao XG; Xu X; Wang GH; Lei M; Quan LL; Cheng YH; Wan P; Zhou JP; Chen J; Hu LH; Shen X
    J Endocrinol; 2015 Mar; 224(3):327-41. PubMed ID: 25572265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.